CS173691A3 - Derivatives of /(1-arylpyrrolidin-2-yl)methyl/piperazine, process for their preparation and their use in therapy - Google Patents
Derivatives of /(1-arylpyrrolidin-2-yl)methyl/piperazine, process for their preparation and their use in therapy Download PDFInfo
- Publication number
- CS173691A3 CS173691A3 CS911736A CS173691A CS173691A3 CS 173691 A3 CS173691 A3 CS 173691A3 CS 911736 A CS911736 A CS 911736A CS 173691 A CS173691 A CS 173691A CS 173691 A3 CS173691 A3 CS 173691A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- group
- compounds
- solvent
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9007067A FR2663026B1 (fr) | 1990-06-07 | 1990-06-07 | Derives de [(1-arylpyrrolidin-2-yl) methyl] piperazine, leur preparation et leur application en therapeutique. |
Publications (1)
Publication Number | Publication Date |
---|---|
CS173691A3 true CS173691A3 (en) | 1992-02-19 |
Family
ID=9397358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS911736A CS173691A3 (en) | 1990-06-07 | 1991-06-06 | Derivatives of /(1-arylpyrrolidin-2-yl)methyl/piperazine, process for their preparation and their use in therapy |
Country Status (21)
Country | Link |
---|---|
US (1) | US5192763A (xx) |
EP (1) | EP0461012B1 (xx) |
JP (1) | JPH04235958A (xx) |
KR (1) | KR100188902B1 (xx) |
AT (1) | ATE104662T1 (xx) |
AU (1) | AU634391B2 (xx) |
CA (1) | CA2043981A1 (xx) |
CS (1) | CS173691A3 (xx) |
DE (1) | DE69101740T2 (xx) |
DK (1) | DK0461012T3 (xx) |
ES (1) | ES2054460T3 (xx) |
FI (1) | FI97055C (xx) |
FR (1) | FR2663026B1 (xx) |
HU (1) | HU209620B (xx) |
IE (1) | IE64688B1 (xx) |
IL (1) | IL98372A (xx) |
NO (1) | NO177931C (xx) |
NZ (1) | NZ238431A (xx) |
PL (1) | PL165187B1 (xx) |
PT (1) | PT97885B (xx) |
ZA (1) | ZA914339B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1245712B (it) * | 1991-04-09 | 1994-10-14 | Boehringer Mannheim Italia | Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree |
FR2684374B1 (fr) * | 1991-12-02 | 1995-05-19 | Synthelabo | Derives substitues de 1-[(1-arylpyrrolidin-2-yl)methyl]piperazine, leur preparation et leur application en therapeutique. |
IT1255704B (it) * | 1992-09-30 | 1995-11-10 | Boehringer Mannheim Italia | Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3250771A (en) * | 1962-12-17 | 1966-05-10 | Geigy Chem Corp | 5-monocarbocyclic aryl-n-lower alkyl-2-pyrrolidine carboxylic acid, esters, amides and derivatives thereof |
GB1428493A (en) * | 1973-05-02 | 1976-03-17 | Science Union & Cie | Heterocyclic amides processes for their preparation and pharma ceutical compositions containing them |
US5063242A (en) * | 1989-04-21 | 1991-11-05 | Warner-Lambert Company | 7-((substituted)amino)-8-((substituted)carbonyl)-methylamino-1-oxaspiro[4,5]decanes as diuretics antiinflammatory, and cerebrovascular agents |
-
1990
- 1990-06-07 FR FR9007067A patent/FR2663026B1/fr not_active Expired - Fee Related
-
1991
- 1991-06-03 DE DE69101740T patent/DE69101740T2/de not_active Expired - Fee Related
- 1991-06-03 AT AT9191401431T patent/ATE104662T1/de not_active IP Right Cessation
- 1991-06-03 DK DK91401431.1T patent/DK0461012T3/da active
- 1991-06-03 ES ES91401431T patent/ES2054460T3/es not_active Expired - Lifetime
- 1991-06-03 EP EP91401431A patent/EP0461012B1/fr not_active Expired - Lifetime
- 1991-06-04 IL IL9837291A patent/IL98372A/en not_active IP Right Cessation
- 1991-06-06 FI FI912733A patent/FI97055C/fi active
- 1991-06-06 US US07/710,711 patent/US5192763A/en not_active Expired - Fee Related
- 1991-06-06 AU AU78196/91A patent/AU634391B2/en not_active Ceased
- 1991-06-06 PT PT97885A patent/PT97885B/pt not_active IP Right Cessation
- 1991-06-06 NZ NZ238431A patent/NZ238431A/xx unknown
- 1991-06-06 HU HU911895A patent/HU209620B/hu not_active IP Right Cessation
- 1991-06-06 CS CS911736A patent/CS173691A3/cs unknown
- 1991-06-06 CA CA002043981A patent/CA2043981A1/en not_active Abandoned
- 1991-06-06 ZA ZA914339A patent/ZA914339B/xx unknown
- 1991-06-06 IE IE194191A patent/IE64688B1/en unknown
- 1991-06-06 JP JP3134761A patent/JPH04235958A/ja active Pending
- 1991-06-06 NO NO912168A patent/NO177931C/no not_active IP Right Cessation
- 1991-06-06 PL PL91290572A patent/PL165187B1/pl unknown
- 1991-06-07 KR KR1019910009395A patent/KR100188902B1/ko not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7335670B2 (en) | Derivatives of N-[heteroaryl(piperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics | |
DE60315615T2 (de) | Tricyclische verbindungen basierend auf thiophen und arzneimittel, die diese umfassen | |
PL185029B1 (pl) | Nowa 1-(1,2-dwupodstawiona-piperydynylo)-4-podstawiona pochodna piperazyny, kompozycja farmaceutyczna, sposób wytwarzania kompozycji farmaceutycznej i sposób wytwarzania 1-(1,2-dwupodstawionej-piperydynylo)-4-podstawionej pochodnej piperazyny | |
JP7098663B2 (ja) | ピペリジノンホルミルペプチド2受容体アゴニスト | |
US5210086A (en) | 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapy | |
EP0275696B1 (en) | Piperidine derivatives | |
US7928099B2 (en) | Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists | |
JPH0283375A (ja) | 2−置換ピペラジニル−2−(1,2−ベンズイソキサゾール−3−イル)酢酸誘導体 | |
CA2354213C (en) | N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity | |
AU705683B2 (en) | Piperazino derivatives as neurokinin antagonists | |
AU680626B2 (en) | 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract | |
EA008148B1 (ru) | Новые соединения, их применение и получение | |
US5166156A (en) | Naphthyl piperazines useful as 5-HT1A receptor ligands | |
CS173691A3 (en) | Derivatives of /(1-arylpyrrolidin-2-yl)methyl/piperazine, process for their preparation and their use in therapy | |
DE602004004550T2 (de) | Substituierte heterocyclische verbindungen und anwendungsverfahren | |
KR101771794B1 (ko) | 트리아졸로-아릴아크릴로나이트라일 유도체 및 이의 용도 | |
US5066651A (en) | Pyrrolidone compounds for treating cerebral disorders | |
EP0325984A2 (en) | 5-substituted 1-/4-(1-pyrrolidinyl)-2-butynyl/-2-pyrrolidones and related compounds, a process for their preparation and their use as medicaments | |
IE900027L (en) | New bis(aryl)alkene derivatives, processes for preparing¹them and pharmaceutical compositions containing them | |
US5166157A (en) | Naphthyl piperazines useful as 5-HT1A receptor ligands | |
US5068231A (en) | Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides | |
US5183902A (en) | Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides | |
US5162321A (en) | 1-naphthyl piperazines useful as 5-HT1A receptor ligands | |
US5151418A (en) | Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides | |
US5162324A (en) | Naphyl piperazines useful as 5-HT1A receptor ligands |